ELI LILLY (I4V-MC-JADY)

Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Rheumatoid Arthritis

ELI LILLY (I1F-MC-RHBX)

A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients […]

ELI LILLY (I1F-MC-RHBY)

A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance […]

NOVARTIS (CQAW039A2317)

A 12-week, multicenter, randomized, double-blind, placebo controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care […]

AURINIA (AUR-VCS_2016-01)

A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Orelvo (voclosporin) (23.7 mg Twice Daily) with Placebo in […]

NOVARTIS (CQAW039A2315)

A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy […]

ENANTA PHARMACEUTICALS, INC. (EDP-305)

A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 […]

AURINIA (AUR-VCS_2016-02)

A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Orelvo (voclosporin) (23.7 mg Twice Daily) with Placebo in […]
Founded by physicians in 2006, LCTC Inc., provides an attractive source for conducting phase III-IV clinical research funded by Pharmaceutical, Biotech Companies, Contract Research Organizations or NIH funded trials.
Latin Clinical Trial Center
1801 Ponce de Leon Ave,
Suite 205, San Juan, PR 00909
787-249-4763 (24/7)
787-985-9911
Fax: 787-982-7100
© 2023 Latin Clinical Trial Center. All Rights Reserved.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram